The researchers encouraged clinicians not to rely solely on medication to treat midlife anxiety, as benzodiazepines have been shown to increase mortality in certain groups; they pointed to talk therapy, meditation, and mindfulness-based interventions as possible considerations.
Multimarker inflammatory biosignatures are expected to facilitate diagnosis and predict treatment outcomes for various central nervous system disorders, particularly Alzheimer disease and major depressive disorder.
Clinicians should take depression into careful consideration when treating patients with Alzheimer dementia, as the two conditions combined may predispose patients to cardiovascular disease more than either condition alone.
These findings indicate that anxiety may be a risk factor for late-life dementia, excluding anxiety that is related to prodromal cognitive decline.
These results suggest that antipsychotic exposure has no impact on relative mortality.
The use of certain anticholinergic drugs may increase the risk of future dementia.
Using hearing aids may slow cognitive decline in later life.
These data support the importance of TBI preventative measures and proper management strategies for subsequent dementia.
The findings also suggested that more a more recent diagnosis of psychosis was a greater predictor of the development of dementia, as opposed to cases where patients had been living with psychotic disorder diagnoses for 10 years or more.
Patients with a phonemic advantage at baseline should be followed more closely with a higher index of suspicion for progression to Alzheimer disease.
Researchers concluded that the partnership did not accelerate the overall decline in antipsychotic medication use among study participants.
A study was conducted to assess potential beneficial effects of a lifestyle intervention program on cognition in carriers of the APOE ε4 allele.
Spouses who are affected by dementia may benefit from an at-home dyadic, relationship-focused psychoeducational intervention.
These findings support the recognition of alcohol use disorders as a major risk factor for all dementia types.
There are a handful of biomarkers that offer potential value for predicting the risk for development of MCI symptoms from AD symptoms.
Positive beliefs about age may protect against dementia.
Patients randomly assigned to the intervention experienced a statistically significant improvement in quality of life, agitation, and overall neuropsychiatric symptoms.
Depressive symptoms and apathy were independently associated with incident dementia in community-dwelling older adults.
Michael Thase, MD, comments on the potential for lithium in drinking water as a psychiatric prophylactic agent.
Increased triglyceride levels at midlife are predictive of the presence of β-amyloid 20 years later in cognitively healthy individuals.
There is a greater risk for cognitive decline and impairment in elderly patients who experience age-related hearing loss.
There is limited evidence for the benefits of different interventions to prevent late-life dementia.
Dementia risk was associated with neither proton pump inhibitor exposure nor duration of use.
40% of people with dementia are still driving.
Low and high serum magnesium levels were shown to be associated with increased risk of all-cause dementia.
Although existing management strategies for delirium are limited in effectiveness, researchers are hopeful that improvements in prevention strategies for delirium may be achieved by gaining a better understanding of the role of cognitive and brain reserve.
The use of nursing homes is increasing for those who are cognitively impaired.
A recently published study reports that women who develop high blood pressure in their 40s could be at a higher risk for developing dementia later in life.
Patient behavior is affected with factors associated with readmission in THA patients.
Researchers found that patients with a diagnosis of dementia had a significantly different lithium exposure than controls.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Childhood-Onset Bipolar Disorder Associated With Impaired Family Functioning
- Valproate Use in Women Who Could Become Pregnant: The Argument for Informed Consent
- Sertraline Effective for Treating Depression in Vascular Cognitive Impairment
- Hospitalization Rates in Schizophrenia—Lurasidone vs Quetiapine
- Ketamine-Induced Dissociative Symptoms Predict Antidepressant Response
- Video Games and Exercise as Alternative Therapies for ADHD
- How Parents Can Enhance Autism Treatment: Use of Intervention Strategies at Home
- Electroconvulsive Therapy Effective in Children With Autism
- Comorbid Autism Spectrum Disorder and OCD: Challenges in Diagnosis and Treatment
- The Cutting Edge of Schizophrenia Research: VR as Treatment for Psychosis
- Consensus Statement: Managing Bipolar Disorder During and After Pregnancy
- Verbal Memory Linked to Temporal Lobe Thickness in First-Degree Relatives of Those With Schizophrenia
- Associations Between Maternal Depression, Support, and Cognitive Development in Offspring
- Medical Marijuana Users More Likely to Use Prescription Drugs for Medical, Nonmedical Purposes
- Effects of the 2 Types of Anorexia Nervosa on Bone Metabolism